Insights from Industry RSS Feed - Insights from Industry

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

We at the American Lung Association know that lung cancer is the number one cancer killer among women, however, there is a startling lack of information available to the public regarding lung cancer. [More]
Wearable technology and data analytics in healthcare: an interview with Mark Taglietti and Bob Zemke

Wearable technology and data analytics in healthcare: an interview with Mark Taglietti and Bob Zemke

Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today. [More]
Using refractory metals in cancer treatments: an interview with Robert Desberg, H.C. Starck

Using refractory metals in cancer treatments: an interview with Robert Desberg, H.C. Starck

By developing and producing customized powder morphologies and high-precision mill products, and fabricated and machined components from the refractory metals tungsten, molybdenum, tantalum, and niobium, H.C. Starck makes a significant contribution to enabling cutting-edge developments in innovative high-tech industries. [More]
CRISPR/Cas9 genome editing: an interview with Maja Petkovic

CRISPR/Cas9 genome editing: an interview with Maja Petkovic

RNA guided CRISPR nucleases have a great potential for genome modification in many different organisms. [More]
Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Continuous glucose monitoring (CGM) mobile communications: an interview with Jorge Valdes

Type 1 diabetes is a complex condition to manage. It requires continuous, around the clock monitoring of blood glucose levels, which change repeatedly throughout the day and night. [More]
Maternal age and successful egg freezing with PGS: an interview with Dr. Santiago Munné

Maternal age and successful egg freezing with PGS: an interview with Dr. Santiago Munné

The leading cause of of pregnancy loss or infertility is chromosomal abnormality or imbalance, where extra genetic material is present or some is missing - what’s called aneuploidy. This imbalance leads to the inability to produce viable embryos or pregnancy. [More]
Alport syndrome: an interview with Dr Paul Grint, CMO, Regulus

Alport syndrome: an interview with Dr Paul Grint, CMO, Regulus

Alport Syndrome was first described by a physician called Cecil Alport, back in the late 1920s. It's a genetic disease that affects a certain type of collagen involved in the functioning of the kidney, the ear, and the eye. [More]
Automated biospecimen thawing: an interview with Dr Rolf Ehrhardt, CEO of BioCision

Automated biospecimen thawing: an interview with Dr Rolf Ehrhardt, CEO of BioCision

Surprisingly, even with decades of cryopreservation research, little progress has been made in the way frozen biospecimens are thawed. It’s still very common for researchers and clinicians to thaw cells and other frozen biological samples in a variety of manual ways ... [More]
Surgery simulator app: an interview with Jean Nehme

Surgery simulator app: an interview with Jean Nehme

Touch Surgery is a mobile surgical simulation app that allows surgeons to learn and rehearse surgical procedures. It provides a cognitive map for operations on a virtual patient. [More]
Type 3 interferons and T helper 2 cells: an interview with Grant Gallagher, Managing Director, HUMIGEN

Type 3 interferons and T helper 2 cells: an interview with Grant Gallagher, Managing Director, HUMIGEN

The type 3 interferons - usually called the “lambda” interferons, or “IFNL” - are the most recently identified IFNs. We (myself and Sergei Kotenko) originally identified the receptor and then the three ligands (IFNL1,2,3; very recently a fourth, IFNL4, was discovered); the key paper was published in 2003. [More]
Internet based screening mammography training: an interview with Dr. Holzhauer

Internet based screening mammography training: an interview with Dr. Holzhauer

About half of Radiologists in the USA who participate in breast imaging are estimated to read less than 2,000 screening mammograms per year. This is a suboptimal number, given that only 3-5 cancers in average are seen among 1,000 screening mammograms. [More]
Living with multiple sclerosis (MS): an interview with Gretchen Rubin and Megan Weigel

Living with multiple sclerosis (MS): an interview with Gretchen Rubin and Megan Weigel

Multiple sclerosis, or MS, is a chronic, often disabling disease of the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, moderate, or severe, ranging from numbness in the limbs to paralysis or loss of vision. Approximately 400,000 Americans are living with MS. [More]
Epicure project: an interview with Frédéric Cren

Epicure project: an interview with Frédéric Cren

Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD. [More]
Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

There are a number of challenges, but primarily, it's access to funding. The recent BioCap Conference focussed on the access small businesses have to funding and how that's driven by changes in the market place. [More]
Economic impact of hypoglycaemia: an interview with Dr Klaus Henning Jensen

Economic impact of hypoglycaemia: an interview with Dr Klaus Henning Jensen

Hypoglycaemia is the term used to describe a lower than normal blood sugar level. There are a number of things that actually need to be formally defined in order for a hypoglycaemic episode to be diagnosed. [More]
Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

GEP-NETs stands for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). This is a type of rare cancer that is increasing in incidence and prevalence – more on this later. [More]
Identifying infections rapidly: an interview with Dr. David J. Ecker

Identifying infections rapidly: an interview with Dr. David J. Ecker

Current methods for diagnosing infectious diseases are based on the 150-year-old culture method, where physicians collect a sample of a patient’s tissue, such as blood, mucus or urine, and transfer it onto media bottle to allow the pathogens to grow. [More]
Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure. [More]
Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually. [More]
Overcoming chromatography separation challenges: an interview with Dr. Michael Bavand, ChromaCon, and Dr. Markus Fuchs, Knauer

Overcoming chromatography separation challenges: an interview with Dr. Michael Bavand, ChromaCon, and Dr. Markus Fuchs, Knauer

The biggest challenge in process-scale batch chromatography is how to optimize the yield and throughput at a desired purity. With high target purity in pharmaceuticals and reasonable throughput, yield is usually low and therefore chromatography is considered an expensive high-resolution separation method. [More]